PAVmed, Inc. (PAVM)
2.70
-0.09
(-3.23%)
USD |
NASDAQ |
Oct 12, 16:00
2.70
0.00 (0.00%)
After-Hours: 19:11
PAVmed Free Cash Flow (Quarterly) : -2.676M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.676M |
| March 31, 2026 | -2.642M |
| December 31, 2025 | -1.565M |
| September 30, 2025 | -0.899M |
| June 30, 2025 | -1.186M |
| March 31, 2025 | -1.587M |
| December 31, 2024 | 0.09M |
| September 30, 2024 | -8.889M |
| June 30, 2024 | -11.66M |
| March 31, 2024 | -13.15M |
| December 31, 2023 | -12.06M |
| September 30, 2023 | -11.11M |
| June 30, 2023 | -12.80M |
| March 31, 2023 | -16.31M |
| December 31, 2022 | -17.12M |
| September 30, 2022 | -19.66M |
| June 30, 2022 | -22.91M |
| March 31, 2022 | -12.84M |
| December 31, 2021 | -18.05M |
| September 30, 2021 | -8.053M |
| June 30, 2021 | -6.749M |
| March 31, 2021 | -9.204M |
| December 31, 2020 | -6.736M |
| Date | Value |
|---|---|
| September 30, 2020 | -5.842M |
| June 30, 2020 | -5.598M |
| March 31, 2020 | -3.793M |
| December 31, 2019 | -4.092M |
| September 30, 2019 | -2.878M |
| June 30, 2019 | -2.542M |
| March 31, 2019 | -3.872M |
| December 31, 2018 | -3.022M |
| September 30, 2018 | -1.89M |
| June 30, 2018 | -1.702M |
| March 31, 2018 | -2.200M |
| December 31, 2017 | -1.587M |
| September 30, 2017 | -2.372M |
| June 30, 2017 | -0.8236M |
| March 31, 2017 | -1.830M |
| December 31, 2016 | -1.203M |
| September 30, 2016 | -1.234M |
| June 30, 2016 | -1.508M |
| March 31, 2016 | -0.5312M |
| December 31, 2015 | -0.648M |
| September 30, 2015 | -0.3178M |
| June 30, 2015 | -0.2262M |
| March 31, 2015 | -0.0576M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Abbott Laboratories | 1.991B |
| AngioDynamics, Inc. | -18.48M |
| Alphatec Holdings, Inc. | -1.582M |
| AtriCure, Inc. | 18.43M |
| Baxter International, Inc. | 166.00M |